Journal of the National Cancer Institute Advance Access originally published online on March 11, 2008
JNCI Journal of the National Cancer Institute 2008 100(6):443-444; doi:10.1093/jnci/djn016
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author 2008. Published by Oxford University Press.
CORRESPONDENCE |
Re: C-Reactive Protein and Risk of Breast Cancer
Affiliations of authors: Departments of Environmental Medicine (AZJ, YG, KLK, AAA, PT, RES) and Obstetrics and Gynecology (AAA, PT), New York University School of Medicine, New York (AZJ, YG, KLK, AAA, PT, RES); New York University Cancer Institute, New York (AZJ, KLK, AAA, PT); Netherlands Cancer Institute/Antoni van Leeuwenhoekhuis, Amsterdam, The Netherlands (PFB, JMGB); Radiation Effects Research Foundation, Hiroshima, Japan (RES)
Correspondence to: Anne Zeleniuch-Jacquotte, MD, MS, Department of Environmental Medicine, New York University School of Medicine, 650 1st Ave, Rm 539, New York 10016 (e-mail: anne.jacquotte@med.nyu.edu).
| The first 10% of the full text of this article appears below. |
Zhang et al. (1) reported no association between plasma levels of C-reactive protein (CRP) in apparently healthy women 45 years of age and older and subsequent breast cancer risk. The large study size (892 patients among 27919 participants in the Women's Health Study) argues against lack of power as an explanation for this
Related Article in JNCI
Response to this Correspondence
![]()
CiteULike
Connotea
Del.icio.us What's this?
J Natl Cancer Inst 2007 99: 890-894.
J Natl Cancer Inst 2008 100: 444-445.